Transforming the Hemostasis Diagnostic Devices And Equipment Market in 2025: Rising Incidence Of Cardiovascular Diseases (CVD) In The Elderly Driving Hemostasis Device Utilization In Surgeries

What Is the Expected Size and Growth Rate of the Hemostasis Diagnostic Devices And Equipment Market?
In the recent past, there has been a swift escalation in the market size of hemostasis diagnostic devices and equipment. The market, which was valued at $5.29 billion in 2024, is anticipated to shoot up to $6.18 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 16.8%. Several factors contributed to this historic period growth, including clinical diagnostics, surgical procedures, anticoagulant therapy monitoring, hemophilia, and bleeding disorders.

Expectations indicate a swift expansion in the market size of hemostasis diagnostic devices and equipment over the ensuing years. The market is projected to attain a value of $10.36 billion by 2029, with a compound annual growth rate (CAGR) of 13.8%. Factors like an aging demographic, prevalence of cardiovascular and chronic illnesses, personalized healthcare, and an increase in surgical procedures are driving this growth for the forecasted period. Key trends forecasted for this period include point-of-care testing, use of automation and robots, the discovery of biomarkers, telemedicine, and remote monitoring.

What Factors Are Fueling Growth in the Hemostasis Diagnostic Devices And Equipment Market?
The rising prevalence of disease diagnoses in the elderly has been identified as the main driver behind the increased use of hemostasis devices in cardiovascular disease (CVD) surgeries. As people age, the probability of disease occurrence rises, subsequently leading to a surge in surgeries performed on older patients. Hemostasis devices play a crucial role in enhancing the body's natural blood clotting process and provide monitors for both anticoagulation and transfusion therapy supervision during surgical procedures. A report from the American Heart Association indicates that Americans aged above 80 are at greater risk of acquiring CVDs, with approximately 83% of males and 87.1% of females likely to suffer from some form of the disease. Consequently, the widespread use of hemostasis devices has become instrumental in improving patient comfort and the success rates of these surgeries.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2598&type=smp

Which Leading Companies Are Shaping the Growth of the Hemostasis Diagnostic Devices And Equipment Market?
Major companies operating in the hemostasis diagnostic devices and equipment market include C. R. Bard Inc., Baxter International Inc., Pfizer Inc., Johnson & Johnson, Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Chrono-Log Corporation, CSL Behring LLC, F. Hoffmann-La Roche Ltd., Grifols S.A., HemCon Medical Technologies Inc., Integra Life Sciences Corporation, Medtronic plc, Siemens AG, Thermo Fisher Scientific Inc., Trinity Biotech plc., Ethicon Inc., Boston Scientific Corporation, Olympus Corporation, Cook Group Inc., Halyard Health, Medline Industries Inc., ConMed Corporation, Moog Inc., Argon Medical Devices Inc., B. Braun Interventional Systems Inc., Bio-Rad Laboratories Inc., CareFusion Corporation, Danaher Corporation, DemeTECH Corporation, Diagnostica Stago SAS, Dolphin Sutures, EndoEvolution LLC, Haemonetics Corporation, Internacional Farmacéutica S.A. de C.V., Merit Medical Systems Inc., Quidelortho Corp, STAGO, Stryker Corporation

What Are the Major Trends Shaping the Hemostasis Diagnostic Devices And Equipment Market?
Innovative technology has emerged in the market for hemostasis diagnostic devices and equipment, enhancing the quality and success rate of surgeries. Collagen vascular hemostasis devices represent one such advance. As the primary structural protein in skin and connective tissues, collagen is often purified and used in cosmetic surgeries, but has recently made its debut in the field of hemostasis diagnostic devices. Post-femoral surgery, patients may suffer from immobility and extreme discomfort, so the introduction of collagen-based closure devices has proven beneficial. Based on a study by the American Journal of Neuroradiology surveying 698 instances of Angio-Seal usage, this collagen hemostasis device remarkably lessened the time until mobilization by approximately 15 minutes, with no significant complications. Overall, Angio-Seal contributes to faster hemostasis and enhanced patient mobilization.

What Are the Key Segments of the Hemostasis Diagnostic Devices And Equipment Market?
The hemostasis diagnostic devices and equipment market covered in this report is segmented -

1) By Product: Analyzers, Coagulation Instrument, Other Hemostasis Instruments, Reagents and Kits
2) By Device Technology: Automated, Semi-Automated, Manual
3) By End User: Hospitals, Clinics, Independent Diagnostic, Laboratories, Other End Users

Subsegments:
1) By Analyzers: Hematology Analyzers, Platelet Function Analyzers, Thromboelastography (TEG) Analyzers
2) By Coagulation Instruments: Prothrombin Time (PT) Instruments, Activated Partial Thromboplastin Time (aPTT) Instruments, Fibrinogen Testing Instruments, Thrombin Time (TT) Instruments
3) By Other Hemostasis Instruments: Blood Clotting Time (BCT) Instruments, Bleeding Time (BT) Test Devices, Hemostatic Forceps and Clips
4) By Reagents and Kits: Coagulation Reagents, Blood Collection Kits, Point-of-care Testing Kits, Thrombosis Kits

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Which Region Dominates the Hemostasis Diagnostic Devices And Equipment Market?
North America was the largest region in the global hemostasis diagnostic devices and equipment market in 2023. Asia-Pacific was the second-largest region in the hemostasis diagnostic devices and equipment market. The regions covered in the hemostasis diagnostic devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

What Is Covered In The Hemostasis Diagnostic Devices And Equipment Global Market Report?

- Market Size Analysis: Analyze the Hemostasis Diagnostic Devices And Equipment Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Hemostasis Diagnostic Devices And Equipment Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Hemostasis Diagnostic Devices And Equipment Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Hemostasis Diagnostic Devices And Equipment Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2598

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.